COMBINATION PRODUCT

摘要

A pharmaceutical product comprising, in combination, (i) an indoleamine 2,3- dioxygenase (IDO) inhibitor and (ii) a conjugation product of IFN? and a targeting moiety (TM)or a polynucleotide encoding therefor.